| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 15 | 2018 | 1204 | 3.080 |
Why?
|
| Myocytes, Cardiac | 17 | 2016 | 442 | 2.980 |
Why?
|
| Caveolin 1 | 4 | 2022 | 59 | 2.690 |
Why?
|
| Heart | 4 | 2021 | 850 | 1.770 |
Why?
|
| Integrin beta3 | 6 | 2017 | 35 | 1.670 |
Why?
|
| Cardiomegaly | 11 | 2012 | 213 | 1.370 |
Why?
|
| TOR Serine-Threonine Kinases | 7 | 2016 | 118 | 1.330 |
Why?
|
| Cats | 18 | 2016 | 292 | 1.140 |
Why?
|
| Peptide Fragments | 2 | 2018 | 483 | 1.020 |
Why?
|
| Kidney | 2 | 2021 | 945 | 1.000 |
Why?
|
| Cell Movement | 4 | 2022 | 630 | 0.980 |
Why?
|
| Pressure | 6 | 2017 | 252 | 0.910 |
Why?
|
| src-Family Kinases | 5 | 2017 | 91 | 0.890 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 331 | 0.800 |
Why?
|
| Integrins | 5 | 2015 | 115 | 0.770 |
Why?
|
| Calpain | 4 | 2011 | 205 | 0.770 |
Why?
|
| Monocytes | 1 | 2022 | 210 | 0.750 |
Why?
|
| Animals | 32 | 2022 | 20881 | 0.750 |
Why?
|
| Skin Diseases | 1 | 2022 | 122 | 0.720 |
Why?
|
| Dipeptides | 3 | 2010 | 89 | 0.720 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 157 | 0.710 |
Why?
|
| Protein-Tyrosine Kinases | 7 | 2021 | 195 | 0.690 |
Why?
|
| Ubiquitination | 2 | 2011 | 85 | 0.690 |
Why?
|
| Aorta | 3 | 2017 | 316 | 0.690 |
Why?
|
| Protein Kinases | 3 | 2009 | 122 | 0.670 |
Why?
|
| Cells, Cultured | 13 | 2016 | 2673 | 0.640 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2009 | 73 | 0.640 |
Why?
|
| Angiotensin II | 2 | 2018 | 220 | 0.630 |
Why?
|
| Phosphorylation | 13 | 2015 | 1200 | 0.590 |
Why?
|
| Ribosomal Protein S6 Kinases | 3 | 2007 | 17 | 0.580 |
Why?
|
| Ventricular Function | 1 | 2017 | 93 | 0.560 |
Why?
|
| Sirolimus | 4 | 2011 | 118 | 0.550 |
Why?
|
| Oligopeptides | 5 | 2015 | 152 | 0.540 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2015 | 4 | 0.530 |
Why?
|
| Dasatinib | 1 | 2015 | 17 | 0.520 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 76 | 0.520 |
Why?
|
| Mice | 13 | 2022 | 8474 | 0.500 |
Why?
|
| Aging | 1 | 2021 | 911 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 2791 | 0.500 |
Why?
|
| Proteins | 2 | 2011 | 474 | 0.460 |
Why?
|
| Multiprotein Complexes | 2 | 2014 | 56 | 0.460 |
Why?
|
| Protein Kinase C | 2 | 2007 | 270 | 0.460 |
Why?
|
| Signal Transduction | 11 | 2018 | 2689 | 0.450 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2013 | 28 | 0.440 |
Why?
|
| Blotting, Western | 6 | 2017 | 954 | 0.440 |
Why?
|
| Extracellular Matrix | 2 | 2015 | 493 | 0.430 |
Why?
|
| Hypertrophy | 5 | 2012 | 89 | 0.420 |
Why?
|
| Apoptosis | 5 | 2013 | 1641 | 0.410 |
Why?
|
| Actins | 2 | 2010 | 249 | 0.400 |
Why?
|
| Protein Isoforms | 2 | 2010 | 246 | 0.390 |
Why?
|
| Microtubules | 5 | 2011 | 104 | 0.390 |
Why?
|
| Fibroblasts | 2 | 2015 | 902 | 0.390 |
Why?
|
| Focal Adhesion Kinase 2 | 3 | 2017 | 18 | 0.380 |
Why?
|
| Fibrosis | 3 | 2018 | 371 | 0.380 |
Why?
|
| Ventricular Function, Left | 2 | 2015 | 481 | 0.370 |
Why?
|
| Enzyme Activation | 5 | 2015 | 791 | 0.370 |
Why?
|
| Ventricular Pressure | 2 | 2010 | 82 | 0.350 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 71 | 0.330 |
Why?
|
| Heart Failure | 4 | 2011 | 1180 | 0.310 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 181 | 0.310 |
Why?
|
| Microtubule-Associated Proteins | 5 | 2011 | 114 | 0.310 |
Why?
|
| STAT3 Transcription Factor | 1 | 2008 | 86 | 0.310 |
Why?
|
| RNA 5' Terminal Oligopyrimidine Sequence | 1 | 2007 | 2 | 0.300 |
Why?
|
| Polyribosomes | 1 | 2007 | 24 | 0.300 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2007 | 21 | 0.300 |
Why?
|
| Angiotensins | 2 | 2018 | 16 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2007 | 20 | 0.280 |
Why?
|
| Cell Proliferation | 5 | 2018 | 1174 | 0.280 |
Why?
|
| Cytoskeletal Proteins | 2 | 2006 | 108 | 0.280 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 89 | 0.260 |
Why?
|
| Ubiquitin | 1 | 2006 | 74 | 0.260 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2014 | 16 | 0.260 |
Why?
|
| Caspase 3 | 3 | 2011 | 233 | 0.240 |
Why?
|
| RNA, Messenger | 2 | 2013 | 1664 | 0.240 |
Why?
|
| Focal Adhesions | 3 | 2015 | 25 | 0.240 |
Why?
|
| Constriction, Pathologic | 2 | 2017 | 236 | 0.230 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 807 | 0.230 |
Why?
|
| Heart Ventricles | 2 | 2006 | 738 | 0.210 |
Why?
|
| Genes, Dominant | 3 | 2008 | 51 | 0.210 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1692 | 0.200 |
Why?
|
| Bleomycin | 1 | 2022 | 67 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 82 | 0.200 |
Why?
|
| Male | 9 | 2021 | 37321 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 710 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 250 | 0.190 |
Why?
|
| Focal Adhesion Kinase 1 | 2 | 2015 | 20 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1745 | 0.180 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2011 | 40 | 0.180 |
Why?
|
| Cell Survival | 3 | 2009 | 901 | 0.180 |
Why?
|
| Cell Nucleus | 2 | 2015 | 305 | 0.170 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1083 | 0.160 |
Why?
|
| Capillary Permeability | 1 | 2018 | 69 | 0.160 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1174 | 0.160 |
Why?
|
| Injections, Intravenous | 2 | 2009 | 215 | 0.160 |
Why?
|
| Collagen | 3 | 2018 | 636 | 0.160 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 79 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 2550 | 0.150 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 217 | 0.150 |
Why?
|
| Serine | 2 | 2015 | 99 | 0.150 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 140 | 0.150 |
Why?
|
| Time Factors | 4 | 2009 | 4655 | 0.150 |
Why?
|
| Graphite | 1 | 2018 | 46 | 0.150 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2017 | 2 | 0.140 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2010 | 117 | 0.140 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 41 | 0.140 |
Why?
|
| Cricetinae | 2 | 2015 | 262 | 0.140 |
Why?
|
| Collagen Type I | 1 | 2017 | 175 | 0.130 |
Why?
|
| Phenylephrine | 1 | 2016 | 61 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 102 | 0.130 |
Why?
|
| Constriction | 1 | 2015 | 37 | 0.130 |
Why?
|
| Flow Cytometry | 1 | 2017 | 489 | 0.130 |
Why?
|
| Gene Expression | 2 | 2017 | 770 | 0.130 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 55 | 0.130 |
Why?
|
| Cricetulus | 1 | 2015 | 98 | 0.130 |
Why?
|
| CHO Cells | 1 | 2015 | 161 | 0.130 |
Why?
|
| Arterial Pressure | 1 | 2015 | 47 | 0.130 |
Why?
|
| Adenoviridae | 4 | 2004 | 295 | 0.130 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2007 | 138 | 0.120 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2014 | 80 | 0.120 |
Why?
|
| Models, Biological | 2 | 2008 | 981 | 0.110 |
Why?
|
| Arrestins | 1 | 2014 | 92 | 0.110 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2013 | 14 | 0.110 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2003 | 27 | 0.110 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2012 | 15 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 25 | 0.110 |
Why?
|
| RNA Stability | 1 | 2013 | 55 | 0.110 |
Why?
|
| S100 Proteins | 1 | 2012 | 42 | 0.100 |
Why?
|
| Fibronectins | 1 | 2012 | 130 | 0.100 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2011 | 4 | 0.100 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2011 | 7 | 0.100 |
Why?
|
| Insulin | 2 | 2007 | 619 | 0.100 |
Why?
|
| Cell Division | 2 | 2003 | 541 | 0.100 |
Why?
|
| Rats | 3 | 2014 | 5300 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 175 | 0.100 |
Why?
|
| Propranolol | 1 | 2011 | 103 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2012 | 324 | 0.100 |
Why?
|
| Myocardial Contraction | 2 | 2010 | 383 | 0.100 |
Why?
|
| Rats, Inbred F344 | 1 | 2011 | 104 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 215 | 0.090 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2010 | 9 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 206 | 0.090 |
Why?
|
| Myosin Heavy Chains | 2 | 2007 | 49 | 0.090 |
Why?
|
| Biomarkers | 1 | 2015 | 1593 | 0.090 |
Why?
|
| Models, Animal | 1 | 2011 | 252 | 0.090 |
Why?
|
| Protein Binding | 2 | 2003 | 1027 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 87 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 284 | 0.080 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 47 | 0.080 |
Why?
|
| Gelsolin | 1 | 2008 | 6 | 0.080 |
Why?
|
| Tubulin | 2 | 2011 | 60 | 0.080 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2008 | 24 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 133 | 0.080 |
Why?
|
| Caspase Inhibitors | 1 | 2008 | 36 | 0.080 |
Why?
|
| Ligation | 1 | 2008 | 83 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 226 | 0.080 |
Why?
|
| Female | 4 | 2021 | 38074 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 160 | 0.080 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2007 | 2 | 0.080 |
Why?
|
| Ribosomal Protein S6 | 1 | 2007 | 3 | 0.080 |
Why?
|
| Protein Phosphatase 1 | 2 | 2011 | 36 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 189 | 0.070 |
Why?
|
| Androstadienes | 1 | 2007 | 41 | 0.070 |
Why?
|
| Histones | 1 | 2008 | 111 | 0.070 |
Why?
|
| Endothelins | 1 | 2007 | 57 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2009 | 453 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 337 | 0.070 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2007 | 4 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 514 | 0.070 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 368 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2009 | 432 | 0.070 |
Why?
|
| Bone Resorption | 1 | 2007 | 64 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2009 | 586 | 0.070 |
Why?
|
| Ventricular Remodeling | 1 | 2009 | 318 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2007 | 308 | 0.070 |
Why?
|
| Humans | 7 | 2017 | 68618 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2007 | 132 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 323 | 0.070 |
Why?
|
| Tyrosine | 2 | 2003 | 196 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1040 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2003 | 202 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2004 | 153 | 0.060 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2003 | 7 | 0.060 |
Why?
|
| Histidine | 1 | 2003 | 17 | 0.060 |
Why?
|
| Vinculin | 1 | 2003 | 15 | 0.060 |
Why?
|
| Integrin beta1 | 1 | 2003 | 48 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2003 | 25 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2003 | 84 | 0.050 |
Why?
|
| Endocytosis | 1 | 2003 | 113 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2003 | 155 | 0.050 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2002 | 4 | 0.050 |
Why?
|
| Butadienes | 1 | 2002 | 26 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 22 | 0.050 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2002 | 22 | 0.050 |
Why?
|
| Threonine | 1 | 2002 | 47 | 0.050 |
Why?
|
| Detergents | 1 | 2002 | 34 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2002 | 56 | 0.050 |
Why?
|
| Nitriles | 1 | 2002 | 68 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 272 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 93 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 223 | 0.050 |
Why?
|
| Protein Phosphatase 2 | 2 | 2011 | 67 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 659 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 929 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2003 | 718 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2011 | 92 | 0.040 |
Why?
|
| Chitosan | 1 | 2018 | 11 | 0.040 |
Why?
|
| Porosity | 1 | 2018 | 63 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 111 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2018 | 212 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2018 | 247 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2010 | 1033 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 32 | 0.030 |
Why?
|
| beta-Arrestins | 1 | 2014 | 80 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 326 | 0.030 |
Why?
|
| Gene Transfer Techniques | 2 | 2004 | 173 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 144 | 0.030 |
Why?
|
| bcl-Associated Death Protein | 1 | 2013 | 19 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 247 | 0.030 |
Why?
|
| CELF1 Protein | 1 | 2013 | 7 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 71 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 56 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 76 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 111 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 317 | 0.030 |
Why?
|
| Sarcomeres | 1 | 2011 | 32 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 14 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2011 | 163 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 251 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 322 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 284 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 508 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 756 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1851 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 629 | 0.020 |
Why?
|
| Tritium | 1 | 2004 | 101 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 1213 | 0.020 |
Why?
|
| Propanolamines | 1 | 2004 | 70 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2004 | 223 | 0.010 |
Why?
|
| Inulin | 1 | 2003 | 5 | 0.010 |
Why?
|
| Occludin | 1 | 2003 | 7 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 2003 | 37 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 447 | 0.010 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2003 | 25 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 59 | 0.010 |
Why?
|
| beta Catenin | 1 | 2003 | 73 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 237 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 282 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 615 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 947 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 617 | 0.010 |
Why?
|
| Age Factors | 1 | 2003 | 1864 | 0.010 |
Why?
|